Aptar PharmaCompany NewsAptar Pharma Completes First Phase of Global Injectables Expansion ProgramThe multisite, international expansion project began in 2020 and is intended to significantly boost ...
Aptar PharmaCompany NewsAptar Pharma to host three insightful Learning Lab sessionsAptar Pharma will host three insightful Learning Lab sessions on Wednesday, February 5 at Pharmapack...
Aptar PharmaProduct InfoAptar Pharma QuickStart Injectables wins Industry Innovation Award at Pharmapack 2019Aptar Pharma, a leading provider of innovative drug delivery systems, has announced that their recen...
Aptar PharmaCompany NewsAptar Pharma showcases PureHale and QuickStartTM Injectables product launchesAs part of the Innovation Gallery at Pharmapack this year, Aptar Pharma will showcase two of their n...
Aptar PharmaCompany News Aptar Pharma's Preservative-Free Multidose Dispenser approved for anti-allergy treatment by French regulatory agency ANSMAptar Pharma’s innovative, preservative-free multidose Ophthalmic Squeeze Dispenser is the approved ...
Aptar PharmaCompany NewsPulmonary and nasal drug delivery experts to attend RDD Europe 2017Register now to attend the RDD Europe 2017 Scientific Conference to be held April 25-28, 2017, in A...
Aptar PharmaCompany NewsPulmonary and Nasal Drug Delivery Experts to attend RDD Europe 2017The Respiratory Drug Delivery (RDD®) Europe 2017 scientific conference will welcome pulmonary and na...
.jpg)
